Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

2 results
Filters applied: . Clear all
Page 1
Filgotinib: First Approval.
Dhillon S, Keam SJ. Dhillon S, et al. Drugs. 2020 Dec;80(18):1987-1997. doi: 10.1007/s40265-020-01439-0. Drugs. 2020. PMID: 33237566 Review.
In the EU, filgotinib is indicated for the treatment of moderate to severe active rheumatoid arthritis (RA) in adults who have responded inadequately to, or who are intolerant to, one or more disease-modifying anti-rheumatic drugs (DMARDs). In Japan, filgotinib is indicate …
In the EU, filgotinib is indicated for the treatment of moderate to severe active rheumatoid arthritis (RA) in adults who have responded ina …
Sofpironium Bromide: First Approval.
Paik J. Paik J. Drugs. 2020 Dec;80(18):1981-1986. doi: 10.1007/s40265-020-01438-1. Drugs. 2020. PMID: 33236266 Review.
Feedback